Innovative C-Level Executive Advisory Solutions for Private Biotechnology Companies

We Pioneered a Compliant Solution that Enables the Most Successful C-Level Executive Fundraisers to Help Private Biotechs Who Are Raising Capital Through Private-PIPEs

  • Biopharmaceutical
  • Medical Device
  • Diagnostic
  • AI-driven Healthtech
  • Drug Delivery

Collabrity Executive Advisors (CEAs) have Proven Biotech Private-PIPE Fundraising Track Records

  • Currently available CEAs are Board members with CEO/CFO backgrounds and have closed over $1 billion in Biotech Private-PIPEs
  • Continuity Prized by Investors – CEAs continue post-financing in an operating or advisory role of your choosing
  • Global Reach – the impact of CEAs is amplified by Collabrity’s Founder, Associates, and proprietary investor qualification technology, resulting in 5x more hours/month of support for your financing campaign vs. placement agents, more comprehensive outreach to qualified investors around the world, and a search that is not restricted to only one individual’s or one firm’s network

AnNie Qi™ – Human-in-the-loop Precision Financing for the Precision Medicine Era

Try it out at AnNie QiTM

  • 500+ profiled Private-PIPE Biotech investor database and created using our proprietary Artificial Intelligence / Natural Intelligence technology for Qualifying Investment or AnNie Qi™, this site demonstrates the powerful tools Collabrity brings to supporting private biotechnology company CEOs and investors.

The Collabrity Report Curates and Updates AnNie Qi™ – Our Private-PIPE Investor Database

  • Collabrity Report is now the most comprehensive free online resource for current biopharma financings worldwide
  • “The Collabrity Report is a strong compendium of financing events, great for the field.”

    David Schaffer
    Director, QB3
    Hubbard Howe Distinguished Professor, UC Berkeley

Source: Timothy E. Morris | LinkedIn

Highly-Qualified Executive Advisor Support

  • Seasoned Leadership & Expertise – a career in biotechnology spanning business development and financial leadership roles encompassing all aspects of CBO / CFO’s responsibilities
    • 28 partnering and financing transactions totaling over $950 million in announced value

© , all rights reserved

Contact Christopher Lehman, Founder

Fill out this field
Please enter a valid email address.
Fill out this field

In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive Advisor(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.

Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck

The reader agrees to the provisions set forth on those certain “Disclaimers” located at https:/www.finalis.com/disclaimers and the terms thereof are incorporated by reference as though fully set forth herein, and references therein to (i) “Company” means the entity in connection with this transaction (together with its affiliates, subsidiaries, successors and assigns), (ii) “Banker” means the registered representative of Finalis Securities LLC in connection with this transaction and (iii) “Bank” means Collabrity inc. An investment in a private placement is highly speculative and involves a high degree of risk, including the potential loss of the entire investment.